 | Up a level |
Smith, MR; Egerdie, B; Hernández Toriz, N; Feldman, R; Tammela, TL; Saad, F; Heracek, J; Szwedowski, M; Ke, C; Kupic, A; Leder, BZ; Goessl, C; Denosumab, HALT Prostate Cancer Study Group (2009). Denosumab in men receiving androgen-deprivation therapy for prostate cancer. New England journal of medicine NEJM, 361(8), pp. 745-755. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0809003
